Valuation: Bio-Rad Laboratories, Inc.

Market Cap 9.99B 8.95B 8.23B 7.46B 13.94B 948B 14.2B 98.13B 39.39B 499B 37.49B 36.69B 1,573B P/E 2026 *
44.7x
P/E 2027 * 43.7x
Enterprise Value 9.24B 8.27B 7.61B 6.9B 12.89B 877B 13.13B 90.77B 36.44B 461B 34.67B 33.94B 1,455B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.44x
Free-Float
60.17%
Yield 2026 *
-
Yield 2027 * -
1 day-3.18%
1 week+0.60%
1 month+4.67%
3 months+14.35%
6 months+45.07%
Current year+22.84%
1 week 368.44
Extreme 368.445
390.16
1 month 347.29
Extreme 347.29
390.16
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
784.39
10 years 163.27
Extreme 163.27
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
9/6/26 Exercice

General Counsel

1,841 0.0085%
9/6/26 Exercice

Chief Executive Officer

8,764 0.0404%
9/6/26 Exercice

Chief Financial Officer

3,854 0.0178%
Change 5-day change 1-year change 3-year change Capi.($)
-3.18%+0.60%+16.47%+34.12% 9.99B
+1.56%+2.41%-14.09%+11.78% 184B
-0.59%+1.18%+6.44%+36.26% 118B
-6.38%-4.98%-18.07%+7.28% 111B
+1.00%+6.40%-41.26%+6.05% 94.58B
+0.09%-0.05%-2.06%+76.70% 63.13B
-5.48%-5.11%-1.45%+61.88% 55.66B
-0.23%-0.52%+10.73%-22.03% 53.9B
-4.30%-1.64%-12.44%+39.42% 43.42B
+0.20%+2.31%+0.58%-10.02% 34.68B
Average -1.73%+0.11%-5.52%+24.14% 76.84B
Weighted average by Cap. -1.19%+0.24%-10.06%+21.65%

Financials

2026 *2027 *
Net sales 2.57B 2.3B 2.12B 1.92B 3.59B 244B 3.65B 25.24B 10.13B 128B 9.64B 9.44B 405B 2.62B 2.35B 2.16B 1.96B 3.66B 249B 3.73B 25.78B 10.35B 131B 9.85B 9.64B 413B
Net income 225M 201M 185M 168M 314M 21.35B 320M 2.21B 887M 11.23B 844M 826M 35.42B 230M 206M 189M 171M 321M 21.81B 327M 2.26B 906M 11.47B 862M 844M 36.18B
Net Debt -749M -671M -617M -559M -1.05B -71.12B -1.06B -7.36B -2.95B -37.41B -2.81B -2.75B -118B -965M -865M -795M -721M -1.35B -91.67B -1.37B -9.48B -3.81B -48.22B -3.62B -3.55B -152B
Projected Income Statement - Annual - Bio-Rad Laboratories, Inc.
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-10-30 US$372.18 -3.18% 183,089
26-10-29 US$384.40 -0.19% 332,347
26-10-28 US$385.12 +1.08% 251,325
26-10-27 US$380.99 +2.30% 167,160
26-10-26 US$372.43 +0.67% 179,100
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bio-Rad Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
372.18USD
Average target price
335.00USD
Spread / Average Target
-9.99%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bio-Rad Laboratories, Inc.